Marius Pearson

Oxford PharmaGenesis wins prestigious King's Award

We were honoured on Friday as King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM, presented our HealthScience Communications Consultancy with a 2023 King’s Award at our head office just outside Oxford, UK.

Championing diversity and inclusion: Oxford PharmaGenesis proud to be a finalist at the 2023 Communiqué Awards

Oxford PharmaGenesis is proud to have been a finalist for the prestigious 2023 Communiqué Leadership Award for Action on Workforce Diversity and Inclusion. The awards ceremony took place on Thursday 6 July at the Dorchester Hotel, London, UK.

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the third year running

We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.

Social media metrics of plain language summaries on Figshare

Plain language summaries (PLS) present research findings in accessible language and formats and are valuable to many different readers. Journals often use external platforms such as Figshare to host their PLS – but are these locations apparent and visible to readers? We wanted to find out if PLS on Figshare are being shared on social media blogs […]

Learning at Work Week: Oxford PharmaGenesis focuses on supporting colleagues' development

Oxford PharmaGenesis is celebrating another brilliant Learning at Work Week (15–19 May) that has provided colleagues with a packed programme of professional and personal development opportunities.

Celebrating 5 years of working with Asia Pacific clients through our Melbourne office

With a strong biotech and pharmaceutical sector, Melbourne, Australia was the ideal city in which to establish an Oxford PharmaGenesis base for Asia Pacific (APAC). Since 2018, the Melbourne office has seen brilliant growth and success with APAC clients. This year, we celebrate its fifth anniversary and the journey so far. Our Melbourne office opened […]

Enabling Medical Affairs professionals to lead: highlights from the Medical Affairs Professional Society (MAPS) EMEA 2023 workshop on integrated evidence generation planning

Oxford PharmaGenesis colleagues delivered a workshop on integrated evidence generation planning (IEGP) to Medical Affairs professionals at this year’s MAPS EMEA conference (Lisbon) in May. With a holistic and systematic approach, IEGP addresses many common challenges found in evidence generation planning.

Tomas Rees, Oxford PharmaGenesis Director of Innovation, elected as Chair-Elect of the ISMPP Board of Trustees

We are proud to announce that Tomas Rees, Director of Innovation at Oxford PharmaGenesis, has been elected as the Chair-Elect for the ISMPP Board of Trustees. This is a prestigious and influential position that reflects Tomas’s expertise and leadership in the field of medical communications.

Digital health products: unique challenges and exciting opportunities

Digital health products are transforming the healthcare landscape and providing patients with new ways to manage and treat conditions. However, they come with several important considerations for medical communicators, especially when compared with traditional pharmaceuticals, explains Principal Medical Writer Caroline Leitschuh.

Oxford PharmaGenesis honoured with prestigious King's Award for Enterprise

Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country, which recognizes the company’s excellence in International Trade.